SNWV Form 3: Daniel Coyle reports 37 shares and 25,000 option rights
Rhea-AI Filing Summary
SANUWAVE Health, Inc. (SNWV) Form 3 shows Daniel Coyle, the company's Chief Operating Officer and an officer-director, reporting initial beneficial ownership following grants and vesting events. He directly holds 37 shares of common stock and holds options totaling 25,000 underlying shares: a 20,000-share option granted 10/22/2024 exercisable through 10/22/2034 at an exercise price of $14.2, and a second option where 5,000 of the originally granted 10,000 shares vested after achieving two project-based milestones; the remaining 5,000 remain performance‑contingent. The 20,000-share option vests in 12 quarterly installments over three years starting on the grant date. The Form 3 was signed by an attorney-in-fact on 10/06/2025.
Positive
- Equity alignment: Officer holds 25,000 option rights, aligning compensation with shareholder value
- Performance‑based vesting: 5,000 options vested after meeting two project milestones, showing measured payout tied to goals
Negative
- Low current share ownership: Direct ownership of only 37 shares may be viewed as limited immediate stock ownership
- Exercise prices above current market may be required: Options have exercise prices of $14.2 and $27, which could delay or limit economic gain until share price increases
Insights
Officer filing documents direct ownership of 37 shares and 25,000 option rights.
The filing records that Daniel Coyle, the COO, directly owns 37 common shares and holds options covering 25,000 underlying shares with stated exercise prices of $14.2 and $27. The larger option (20,000) vests quarterly over three years from 10/22/2024, and a performance‑based grant originally for 10,000 has 5,000 vested due to two met milestones.
This disclosure is administrative and customary for officers receiving equity compensation; the material items to watch are further vesting triggers and any exercises or sales that would change reported ownership in subsequent Section 16 filings within the required reporting windows.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Stock Option (right to buy) | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (2)
- F1. Options vest over a period of three years in 12 equal installments on each quarterly anniversary of the grant date. These options were granted to the reporting person on October 22, 2024.
- F2. On June 4, 2025, the reporting person was granted options to purchase 10,000 shares of common stock that vest in four equal installments based on the satisfaction of certain project-based performance milestones. Two of the performance milestones have been met, resulting in the vesting of 5,000 options.
AI-generated analysis. How Rhea-AI works. Not financial advice.
